KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid

KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid

Bempedoic acid (BemA) is an ATP-citrate lyase (ACLY) inhibitor used to treat hypercholesterolemia. We studied the anti-steatotic effect of BemA, and the mechanisms involved, in a model of fatty liver in female rats obtained through the administration of a high-fat diet supplemented with liquid fruct...

Full description

Bibliographic Details
Main Authors:	Ana Magdalena Velázquez, Roger Bentanachs, Aleix Sala-Vila, Iolanda Lázaro, Jose Rodríguez-Morató, Rosa María Sánchez, Juan Carlos Laguna, Núria Roglans, Marta Alegret
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Biomedicines
Subjects:	NAFLD triglycerides fructose bempedoic acid fructokinase β-oxidation
Online Access:	https://www.mdpi.com/2227-9059/10/7/1517

Similar Items

Bempedoic Acid Restores Liver H<sub>2</sub>S Production in a Female Sprague-Dawley Rat Dietary Model of Non-Alcoholic Fatty Liver
by: Núria Roglans, et al.
Published: (2022-12-01)

Severe hypertriglyceridemia after use of bempedoic acid
by: Valentin Bovy, et al.
Published: (2023-04-01)

MdFRK2-mediated sugar metabolism accelerates cellulose accumulation in apple and poplar
by: Jing Su, et al.
Published: (2021-06-01)

The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023-01-01)

Identification and biochemical characterization of the fructokinase gene family in Arabidopsis thaliana
by: John W. Riggs, et al.
Published: (2017-04-01)

Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
by: Richard J. Johnson, et al.
Published: (2020-09-01)

Hexose kinases and their role in sugar-sensing and plant development
by: David eGranot, et al.
Published: (2013-03-01)

Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020-08-01)

Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
by: Ovidio De Filippo, et al.
Published: (2023-11-01)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
by: Ramyashree Tummala, et al.
Published: (2022-12-01)

Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice
by: Kenneth R. Hallows, et al.
Published: (2022-11-01)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Alessandro Di Minno, et al.
Published: (2020-08-01)

Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis
by: Xing Wang, et al.
Published: (2020-08-01)

Adipose Tissue Protects against Hepatic Steatosis in Male Rats Fed a High-Fat Diet plus Liquid Fructose: Sex-Related Differences
by: Roger Bentanachs, et al.
Published: (2023-09-01)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
by: Gianni Biolo, et al.
Published: (2022-10-01)

Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations
by: Uma Sai Teja Yarra, et al.
Published: (2021-10-01)

Untangling the relationship between bempedoic acid and gout: results from a systematic literature review
by: Alessia Alunno, et al.
Published: (2023-10-01)

Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation
by: Benny M. Amore, et al.
Published: (2023-05-01)

Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
by: Akshyaya Pradhan, et al.
Published: (2023-04-01)

Clinical efficacy and safety outcomes of bempedoic acid: An updated systematic review and meta-analysis after CLEAR Outcomes trial
by: Amit Bhandari, et al.
Published: (2023-12-01)

Characterization of novel stress degradation products of Bempedoic acid and Ezetimibe using UPLC–MS/MS: development and validation of stability-indicating UPLC method
by: Anuradha Vejendla, et al.
Published: (2021-12-01)

Computational Modeling of Fructose Metabolism and Development in NAFLD
by: Yunjie Liao, et al.
Published: (2020-07-01)

Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity
by: Tamás G. Gergely, et al.
Published: (2023-01-01)

Bempedoic acid: mechanism of action and therapeutic use in atherosclerotic cardiovascular diseases and diabetes
by: V.A. Serhiyenko, et al.
Published: (2023-05-01)

Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats
by: Angezwa Siboto, et al.
Published: (2022-10-01)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
by: Xiaoming Jia, et al.
Published: (2019-04-01)

Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease
by: Claudio Bilato, et al.
Published: (2022-04-01)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023-09-01)

Osthol Ameliorates Kidney Damage and Metabolic Syndrome Induced by a High-Fat/High-Sugar Diet
by: Fernando E. García-Arroyo, et al.
Published: (2021-02-01)

Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
by: Xiang Zhao, et al.
Published: (2020-12-01)

Case report: Strong low-density-cholesterol reduction accompanied by shrinkage of low-attenuation coronary plaque during lipid-lowering treatment with bempedoic acid—serial evaluation by coronary computed tomography angiography
by: Grigorios Korosoglou, et al.
Published: (2023-08-01)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
by: Abhijit Pratap, et al.
Published: (2023-10-01)

mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars
by: Gemma Sangüesa, et al.
Published: (2019-03-01)

TWIN SISTER OF FT (TSF) Interacts with FRUCTOKINASE6 and Inhibits Its Kinase Activity in Arabidopsis
by: Suhyun Jin, et al.
Published: (2017-10-01)

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
by: Mattia Coronati, et al.
Published: (2022-03-01)

In response to: Steatotic liver disease-know your enemies
by: Michael H. Le, et al.
Published: (2024-04-01)

Utilization of exogenous free fatty acids for the production of very low density lipoprotein triglyceride by livers of carbohydrate-fed rats
by: G. SCHONFELD, et al.
Published: (1971-09-01)

Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet
by: Ying Zhang, et al.
Published: (2022-09-01)

Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation
by: Ana Magdalena Velázquez, et al.
Published: (2020-10-01)

Sugar and acid profile of loquat (Eriobotrya japonica Lindl.), enzymes assay and expression profiling of their metabolism-related genes as influenced by exogenously applied boron
by: Muhammad Moaaz Ali, et al.
Published: (2022-10-01)